@ARTICLE{
author={Zimran Ari,Duran Gloria,Giraldo Pilar,Rosenbaum Hanna,Giona Fiorina,Petakov Milan S,Terreros Munoz Eduardo,Eduardo Solorio-Meza Sergio,Cooper Peter A,Varughese Sheeba,Alon Sari,Chertkoff Raul},
year={2019},
title={Long-term efficacy and safety results of taliglucerase alfa through 5 years in adult treatment-naive patients with Gaucher disease},
journal={BLOOD CELLS MOLECULES AND DISEASES},
volume={78},
number={},
pages={14-21},
document_type={Article},
} 

@ARTICLE{
author={Zimran Ari,Gonzalez-Rodriguez Derlis Emilio,Abrahamov Aya,Cooper Peter A,Varughese Sheeba,Giraldo Pilar,Petakov Milan S,Tan Ee Shien,Chertkoff Raul},
year={2018},
title={Long-term safety and efficacy of taliglucerase alfa in pediatric Gaucher disease patients who were treatment-naive or previously treated with imiglucerase},
journal={BLOOD CELLS MOLECULES AND DISEASES},
volume={68},
number={},
pages={163-172},
document_type={Article},
} 

@ARTICLE{
author={Pastores Gregory M,Shankar Suma P,Petakov Milan S,Giraldo Pilar,Rosenbaum Hanna,Amato Dominick J,Szer Jeffrey,Chertkoff Raul,Brill-Almon Einat,Zimran Ari},
year={2016},
title={Enzyme replacement therapy with taliglucerase alfa: 36-month safety and efficacy results in adult patients with Gaucher disease previously treated with imiglucerase},
journal={AMERICAN JOURNAL OF HEMATOLOGY},
volume={91},
number={7},
pages={661-665},
document_type={Article},
} 

@ARTICLE{
author={Zimran Ari,Duran Gloria,Mehta Atul,Giraldo Pilar,Rosenbaum Hanna,Giona Fiorina,Amato Dominick J,Petakov Milan S,Munoz Eduardo Terreros,Solorio-Meza Sergio Eduardo,Cooper Peter A,Varughese Sheeba,Chertkoff Raul,Brill-Almon Einat},
year={2016},
title={Long-term efficacy and safety results of taliglucerase alfa up to 36 months in adult treatment-naive patients with Gaucher disease},
journal={AMERICAN JOURNAL OF HEMATOLOGY},
volume={91},
number={7},
pages={656-660},
document_type={Article},
} 

@ARTICLE{
author={Pastores Gregory M,Petakov Milan S,Giraldo Pilar,Rosenbaum Hanna,Szer Jeffrey,Deegan Patrick B,Amato Dominick J,Mengel Eugen,Tan Ee Shien,Chertkoff Raul,Brill-Almon Einat,Zimran Ari},
year={2014},
title={A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase},
journal={BLOOD CELLS MOLECULES AND DISEASES},
volume={53},
number={4},
pages={253-260},
document_type={Article},
} 

@ARTICLE{
author={Biegstraaten Marieke,Wesnes Keith A,Luzy Cecile,Petakov Milan S,Mrsic Mirando,Niederau Claus,Giraldo Pilar,Hughes Derralyn,Mehta Atul,Mengel Karl-Eugen,Hollak Carla EM,Marodi Laszlo,van Schaik Ivo N},
year={2012},
title={The cognitive profile of type 1 Gaucher disease patients},
journal={JOURNAL OF INHERITED METABOLIC DISEASE},
volume={35},
number={6},
pages={1093-1099},
document_type={Article},
} 

@ARTICLE{
author={Biegstraaten Marieke,Mengel Eugen,Marodi Laszlo,Petakov Milan S,Niederau Claus,Giraldo Pilar,Hughes Derralyn,Mrsic Mirando,Mehta Atul,Hollak Carla EM,van Schaik Ivo N},
year={2010},
title={Peripheral neuropathy in adult type 1 Gaucher disease: a 2-year prospective observational study},
journal={BRAIN},
volume={133},
number={},
pages={2909-2919},
document_type={Article},
}